Tulio Rodriguez practices Hematology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Tulio Rodriguez is a published MD. He has 12 papers published. The most current publication "Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood..." Tulio E. Rodriguez, MD is registered with Medicare.
NPI NUMBER | 1831176007 | |
NPPES Provider LastName | RODRIGUEZ | |
NPPES Provider FirstName | TULIO | |
NPPES Provider ZIPCode | 60153 | |
NPPES Provider State | IL | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 472.0 | |
Distinct Opioid Count | 2.0 | |
Opioid Claim Count | 41.0 | |
Percent Opioid Claims | 8.69 |
National Provider Identifier [NPI] | 1831176007 |
Last Name Of The Provider | RODRIGUEZ |
First Name Of The Provider | TULIO |
View All |
Dr. Janelle M. Meyer, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Kathy S. Albain, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Shelly Lo, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Yanxia Li, MD | |
Dr. Urszula A. Sobol, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Shams B. Bakhos, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Malini M. Patel, MD | |
Dr. Kathrine A. Wentland, MD |